tiprankstipranks
Trending News
More News >
Xenetic Biosciences (XBIO)
NASDAQ:XBIO
US Market

Xenetic Biosciences (XBIO) Income Statement

Compare
295 Followers

Xenetic Biosciences Income Statement

Last quarter (Q4 2024), Xenetic Biosciences's total revenue was $648.82K, a decrease of -3.44% from the same quarter last year. In Q4, Xenetic Biosciences's net income was $-1.05M. See Xenetic Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.50M$ 2.54M$ 1.71M$ 1.16M$ 436.94K
Gross Profit
$ 2.50M$ 2.54M$ 1.68M$ 1.13M$ 436.94K
Operating Expenses
$ 6.70M$ 7.06M$ 8.42M$ 6.91M$ 5.13M
Depreciation and Amortization
$ 0.00$ -28.21K$ 27.04K$ 35.48K$ 28.84K
EBITDA
$ -4.20M$ -4.54M$ -6.72M$ -5.71M$ -4.69M
Operating Income
$ -4.20M$ -4.52M$ -6.72M$ -5.75M$ 4.55M
Other Income/Expenses
$ 244.15K$ 381.14K$ 165.56K$ 101.59K$ 125.68K
Pretax Income
$ -3.96M$ -4.13M$ -6.55M$ -5.65M$ -13.81M
Net Income
$ -3.96M$ -4.13M$ -6.39M$ -5.54M$ -10.89M
Per Share Metrics
Basic EPS
$ -2.57$ -2.71$ -4.49$ -5.39$ -17.04
Diluted EPS
$ -2.57$ -2.71$ -4.49$ -5.39$ -17.04
Weighted Average Shares Outstanding
1.54M 1.53M 1.42M 1.03M 639.24K
Weighted Average Shares Outstanding (Diluted)
1.54M 1.53M 1.42M 1.03M 639.24K
Currency in USD

Xenetic Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis